0001572426-16-000162.txt : 20160301 0001572426-16-000162.hdr.sgml : 20160301 20160301140026 ACCESSION NUMBER: 0001572426-16-000162 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160225 FILED AS OF DATE: 20160301 DATE AS OF CHANGE: 20160301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nexvet Biopharma plc CENTRAL INDEX KEY: 0001618561 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: UNIT 5, SRAGH TECHNOLOGY PARK STREET 2: RAHAN ROAD CITY: TULLAMORE , CO. OFFALY STATE: L2 ZIP: R35 FR98 BUSINESS PHONE: 353 1 215 8100 MAIL ADDRESS: STREET 1: UNIT 5, SRAGH TECHNOLOGY PARK STREET 2: RAHAN ROAD CITY: TULLAMORE , CO. OFFALY STATE: L2 ZIP: R35 FR98 FORMER COMPANY: FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd DATE OF NAME CHANGE: 20140903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GEARING DAVID CENTRAL INDEX KEY: 0001632481 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36828 FILM NUMBER: 161472558 MAIL ADDRESS: STREET 1: C/O NEXVET BIOPHARMA PLC STREET 2: NATL INST, FOSTERS AVENUE, MOUNT MERRION CITY: BLACKROCK STATE: L2 ZIP: 00000 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-02-25 0001618561 Nexvet Biopharma plc NVET 0001632481 GEARING DAVID C/O NEXVET BIOPHARMA PLC UNIT 5, SRAGH TECHNOLOGY PARK, RAHAN RD TULLAMORE L2 R35 FR98 IRELAND 0 1 0 0 Chief Scientific Officer Ordinary Shares 2016-02-25 4 P 0 19000 3.30 A 102664 I By DJGearing Pty Ltd <Gearing Family Superannuation Fund A/C> Ordinary Shares 2016-02-26 4 P 0 12126 3.34 A 114790 I By DJGearing Pty Ltd <Gearing Family Superannuation Fund A/C> Ordinary Shares 279330 I By Gearing Family Pty Ltd <Gearing FamilyA/C> Ordinary Shares 5600 D The reporting person and his spouse have shared voting and dispositive power with respect to these reported securities. Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $3.25 to $3.35, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. /s/ David Gearing by Geraldine Farrell, Attorney-in-Fact 2016-02-29